FXI Deficiency: Genotype, Phenotype and Management
In the Monday afternoon session entitled Rare Bleeding Disorders, Gillian Gidley reviews the genotypes and phenotypes associated with FXI deficiency, shows data on different diagnostic assays, and covers recommendations for management of patients with FXI deficiency.
The Role of the Laboratory in Diagnosis and Management of Inhibitory Antibodies in Hemophilia
In the Monday morning session entitled Inhibitors: Clinical Aspects, Jan Astermark described the different diagnostic assays laboratories can carry out to measure inhibitors.
Rare Bleeding Disorders: Overview of Clinical Assessment and Diagnosis
In the Monday afternoon session entitled Rare Bleeding Disorders, Flora Peyvandi gives an overview of RBDs in Europe and discusses current technical limitations in laboratory testing, presents current treatments, and also discusses novel treatment strategies.
Gene Therapy for Haemophilia: What, Why, How, When, Who, and Where?
In the Sunday afternoon session entitled Gene Therapy: Back to Basics, Glenn Pierce explains the state of the art and the future prospects of gene therapy, gene editing, and cell therapy, in the context of hemophilia.
State of the Art of the XXXIII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2018 World Congress Glasgow (Vol 24, Issue Supplement S6 Pages 1–94) features reviews of the state of the art of each of the topics of the medical plenaries and sessions at the Congress, written by featured speakers.
Abstracts of the XXXIII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2018 World Congress Glasgow (May 2018, Vol 24, Issue Supplement S5 Pages 1–218) features abstracts of many of the posters presented at the Congress, including Late-Breaking Abstracts and those selected for presentation as Free Papers.
Abstracts of the WFH 15th International Musculoskeletal Congress
Abstracts and program information from the 15th International Musculoskeletal Congress held in Seoul, Republic of Korea, May 5-7, 2017.
Abstracts of the WFH 14th International Musculoskeletal Congress
Abstracts and program information from the 14th International Musculoskeletal Congress held in Belfast, Northern Ireland, May 7 – 10, 2015.
Abstracts of the WFH 13th International Musculoskeletal Congress
Abstracts and program information from the 13th International Musculoskeletal Congress held in Chicago, USA, April 18 – 21, 2013.
Congenital Fibrinogen Disorders: Clinical features and management
In the Wednesday morning session on rare and ultra-rare bleeding disorders, Philippe de Moerloose disscusses the issues of congenital fibrinogen disorders.
Factor FXIII Deficiency
In the Wednesday morning session on rare and ultra-rare bleeding disorders, Diane Nugent presents work on FXIII deficiency.
Health Technology Assessment: Introduction, American perspective, and European perspective
In the Tuesday afternon session on Health Technology Assessments (HTA), Mark Skinner introduces the topic and then Cliff Goodman and Chris Henshall alternate to present the American and European perspectives, respectively.